Ellington Financial Enters Underwriting Agreement for $117.7M Common Stock Offering
summarizeSummary
Ellington Financial Inc. entered into an underwriting agreement for a common stock offering of 8.775 million shares, with an option for an additional 1.316 million shares, priced at $13.40 per share, formalizing the terms of a previously announced capital raise.
check_boxKey Events
-
Underwriting Agreement Signed
Ellington Financial Inc. entered into an underwriting agreement with Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC on January 26, 2026.
-
Offering Details Confirmed
The agreement covers 8,775,000 shares of common stock at a purchase price of $13.40 per share, with an option for underwriters to purchase up to an additional 1,316,250 shares.
-
Substantial Capital Raise
The offering is expected to raise approximately $117.7 million, potentially increasing to $135.2 million if the option is fully exercised.
-
Finalizes Terms of Prior Offering
This agreement finalizes the terms and pricing of the common stock offering that was initiated with a preliminary prospectus on January 26, 2026, and subsequently finalized on January 27, 2026.
auto_awesomeAnalysis
This 8-K filing details the underwriting agreement entered into on January 26, 2026, which finalized the terms and pricing of a common stock offering initiated with a preliminary prospectus on the same date. The offering, which could raise approximately $117.7 million (or up to $135.2 million if the underwriters' option is fully exercised), represents a significant capital raise for the company. The pricing at $13.40 per share, very close to the current market price, indicates investor confidence in the company's ability to secure capital without a deep discount. The proceeds are primarily intended to redeem outstanding preferred stock, which could improve the company's capital structure by reducing fixed obligations.
At the time of this filing, EFC was trading at $13.43 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $11.12 to $14.40. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.